XOMA XOMA Royalty Corp. logo

XOMA XOMA Royalty Corp.

Healthcare
$41.72+0.17%ClosedMarket Cap: $523.2M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

14.00

PEG

0.04

P/B

4.39

P/S

14.42

EV/EBITDA

13.20

DCF Value

$-49.65

FCF Yield

1.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

93.3%

Operating Margin

13.7%

Net Margin

87.0%

ROE

30.2%

ROA

11.6%

ROIC

1.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$12.3M$4.5M$
Q4 null$1.4M$6.1M$
FY null$52.1M$31.7M$
Q3 null$9.4M$14.1M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$53.75

Target (Median)

$50.00

Target Range

$39.00 - $76.00

0 Strong Buy2 Buy3 Hold0 Sell0 Strong Sell
HC Wainwright & Co.Neutral
2026-04-30
HC Wainwright & Co.Buy
2026-03-20
Leerink PartnersOutperform
2026-02-24
HC Wainwright & Co.Buy
2025-12-11
Leerink PartnersOutperform
2025-12-11

Trading Activity

Insider Trades

View All
BVF PARTNERS L P/IL10 percent owner
SellMon May 18
BVF PARTNERS L P/IL10 percent owner
SellMon May 18
BVF PARTNERS L P/IL10 percent owner
SellMon May 18
BVF PARTNERS L P/IL10 percent owner
SellMon May 18
BVF PARTNERS L P/IL10 percent owner
SellMon May 18

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

0.90

XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Peers